Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.050
+0.065 (3.27%)
Oct 19, 2026, 12:44 PM EDT - Market open
LRMR's stock price has decreased by -52.5% in the past year and price targets may not have had time to catch up.
Larimar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $25 | Buy | Maintains | $25 | +1,119.51% | Sep 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +534.15% | Sep 14, 2026 |
| Wedbush | Wedbush | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +436.59% | Aug 5, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $10 | Buy | Initiates | $10 | +387.80% | Jul 2, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +143.90% | Jun 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $9 | Buy | Reiterates | $9 | +339.02% | Jun 30, 2026 |
| Citi | Citi | Buy Maintains $14 | Buy | Maintains | $14 | +582.93% | Jun 30, 2026 |